Merck, Glenmark must face United HealthCare antitrust suit over Zetia, US judge rules
MLex Summary: Merck and Glenmark must face United HealthCare Services’ US claims accusing them of entering into an illegal pay-for-delay agreement that kept a generic version of the cholesterol drug Zetia...To view the full article, register now.
Already a subscriber? Click here to view full article